𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[123I]β-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

✍ Scribed by Walter Pirker; Susanne Asenbaum; Gerhard Bencsits; Daniela Prayer; Willibald Gerschlager; Lüder Deecke; Thomas Brücke

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
925 KB
Volume
15
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Staging disease severity in movement dis
Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration
✍ Emma C. Schofield; Diana Caine; Jillian J. Kril; Nicholas J. Cordato; Glenda M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract The movement disorders progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) both deposit tau in degenerating neurons and are considered to be tauopathies. The recently developed scheme for staging tissue degeneration in another tauopathy, frontotemporal dementia [Bro

Joint and skeletal deformities in Parkin
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
✍ Ramsey Ashour; Joseph Jankovic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract The objective of this study is to characterize clinical features of joint and skeletal deformities in Parkinson's disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). Clinical information including age, gender, presence of deformity, initial symptom sid

Cerebrospinal fluid Aβ42 is reduced in m
Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
✍ Björn Holmberg; Bo Johnels; Kaj Blennow; Lars Rosengren 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract The 42‐amino–acid isoform of β‐amyloid Aβ42 in the cerebrospinal fluid (CSF) has recently been proposed as a biochemical marker for Alzheimer's disease (AD) and subcortical white‐matter dementia (SWD). In both of these conditions, concentration of CSF‐Aβ42 is reduced. We quantified CSF‐